1. Cetin M, Ebrinc S, Agargun MY, Yigit S. Risperidone for the treatment of monosymptomatic hypochondriacal psychosis. J Clin Psychiatry 1999; 60: 554.

2. Basoglu C, Cetin M, Semiz UB, AgargUn MY, Ebrinc S. Premenstrual exacerbation and suicidal behavior in patients with panic disorder. Compr Psychiatry 2000; 41: 103-105.

4. Ebrinc S, Top C, OncUl O, Basoglu C, Cavuslu S, Cetin M. Serum interleukin-1 alpha and interleukin-2 levels in patients with schizophrenia. J Int Med Res 2002; 30: 314-317.

5. Basoglu C, Cetin M, Semiz UB. Hypnotizability, pain treshold and dissociative experiences in patients with borderline personality disorder and self-mutilating behavior. European Neuropsychopharmacology 2002; 12: (Suppl.3) S433-S434.

6. Uzun O, Basoglu C, Cansever A, Ozsahin A, Cetin M, Ebrinc S.: Body dysmorphic disorder in patients with acne. Compr Psychiatry. 2003 Sep-Oct;44(5):415-9.

7. Gultepe M, Ozcan O, Avsar K, Cetin M, Ozdemir AS,Gok M. Urine methylmalonic acid measurements for assessment of cobalamin deficiency related to neuropsychiatric disorders. Clin Biochem 2003;36:275-282.

8. Cetin M, Ebrinç S, Başoğlu C, Semiz UB, Cobanoğlu N, Can S, Karaduman F. Factors affecting the satisfaction of recruits with the military environment.Turk Psikiyatri Derg. 2003 Summer;14(2):125-33.

9. Cetin M, Ebrinc S, Kandilcioglu H,et al. An invesyigation of some brain regions with proton magnetic resonance spectroscopy (1H-MRS) method in patients with first episode and chronic schizophrenia. European Neuropsychopharmacology 2004; 14: (Suppl.3) S239-S239.

10. Semiz UB, Turhan V, Basoglu C, Oner O, Ebrinc S, Cetin M. Leptospirosis presenting with mania and psychosis: four consecutive cases seen in a military hospital in Turkey. Int J Psychiatr Med 2005; 35: 299-305

11. Semiz UB, Basoglu C, Cetin M, Ebrinc S. Panic disorder due to ingestion of single dose ecstasy. Int J Psychiatr Clin Pract 2005; 9: 138-141.

12. Semiz U, Basoglu C, Cetin M, Ebrinc S, Uzun O, Ergun B. Body dysmorphic disorder in patients with borderline personality disorder: A preliminary study. European Neuropsychopharmacology 2005; 15: (Suppl.3) S651-S651.

13. Cetin M, Kose M, Ebrinc; Elhai. Identification and posttraumatic stres disorder symptoms in recue workers in Marmara, Turkey, earthquake. J Traumatic Stress 2005;18:485-489

14. Cetin M, Ebrinc S, Basoglu C, Semiz UB. Efficacy and safety of long-acting injectable risperidone in schizophrenia:a 12 week open-label study in stable patients switched from typical and atypical oral antipsychotics. European Neuropsychopharmacology 2005; 15: (Suppl.2) S134-S135.

15. Basoglu C, Cetin M, Oner O.Comparison of rigth thalamus and temporal cortex metabolite levels of drug-naive first episode psychotic and chronic schizophrenia inpatiens. Turk Psikiyatri Dergisi 2006;17:8591.

16. Cetin M, Karagozoglu M.Olanzapine-induced metabolic side effects, swithing from olanzapine to ziprasidone: A pilot study European Psychiatry 2007; 22: (Suppl.1) S108-S108.

17. Semiz UB, Senol MG, Basoglu C, Noyan O, Ebrinc S, Cetin M, Saracoglu M. Relationship of depressive symptoms and subjective sleep disturbances to the quality of life in patients with Parkinson's disease. Neurol Psychiatr Brain Res 2007; 14: 55-58

18. Semiz UB, Basoglu C, Ebrinc S, Cetin M. Childhood trauma history and dissociative experiences among Turkish men diagnosed with antisocial personality disorder.Soc Psychiatry Psychiatr Epidemiol. 2007 Nov;42(11):865-73. Epub 2007 Aug 24.

19. Semiz UB, Cetin M, Basoglu C, Ebrinc S, Uzun O, Herken H, Balibey H, Algul A, Ates A. Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia.Prog Neuropsychopharmacol Biol Psychiatry. 2007 Aug 15;31(6):1330-6. Epub 2007 Jun 12.

20. Gulsun M, Algul A, Semiz UB, Ates MA, Doruk A, Ebrinc S, Basoglu C, Cetin M. A case with euprolactinemic galactorrhea induced by escitalopram. Int J Psychiatry Med. 2007;37(3):275-8.

21. Ebrinc S, Semiz UB, Basoglu C, Cetin M, Agargun MY, Algul A, Ates A. Self-mutilating behavior in patients with dissociative disorders: the role of innate hypnotic capacity. Isr J Psychiatry Relat Sci. 2008;45(1):39-48.

22. Algul A, Semiz UB, Dundar O, Ates MA, Basoglu C, Ebrinc S, Doruk A, Gecici O, Cetin M. Psychosocial and hormone related risk factors for early postnatal depressive symptoms in turkish women. Neurology, Psychiatry and Brain Research 2008:15: 117-122 ().

23. Semiz UB, Basoglu C, Ebrinc S, Cetin M. Nightmare disorder, dream anxiety, and subjective sleep quality in patients with borderline personality disorder. Psychiatry Clin Neurosci. 2008 Feb;62(1):48-55.

24. Semiz U, Basoglu C, Cetin M, Ebrinc S, Uzun O, Ergun B. Body dysmorphic disorder in patients with borderline personality disorder: prevalence, clinical characteristics, and role of childhood trauma. Acta Neuropsychiatrica 2008: 20: 33-40

25. Basoglu C, Semiz U, Oner O. Gunay H, Ebrinc S, Cetin M, Sildiroglu O, Algul A, Ates A, Sonmez G. A magnetic resonance spectroscopy study of antisocial behavior disorder, psychopathy and violent crime among military conscripts. Acta Neuropsychiatrica 2008: 20: 72-77

26. Semiz UB, Basoglu C, Oner O, Munir KM, Ates A, Algul A, Ebrinc S, Cetin M. Effects of diagnostic comorbidity and dimensional symptoms of attention-deficit-hyperactivity disorder in men with antisocial personality disorder.Aust N Z J Psychiatry. 2008 May;42(5):405-13.

27. Semiz UB, Algül A, Başoğlu C, Ateş MA, Ebrinç S, Cetin M, Güneş C, Günay H. [The relationship between subjective sleep quality and aggression in male subjects with antisocial personality disorder]. Turk Psikiyatri Derg. 2008 Winter;19(4):373-81.

28. Ebrinc S, Algul A, Ates MA, Semiz UB, Gecici O, Basoglu C, Cetin M. Efficacy and safety of long-acting injectable risperidone during treatment of manic episode with non-compliance bipolar patients. Neurol Psychiatr Brain Res 2008: 15: 38-44(

29. Barlas IO, Cetin M, Erdal ME, Semiz UB, Basoglu C, Ay ME, Herken H, Uzun O. Lack of association between DRD3 gene polymorphism and response to clozapine in Turkish schizoprenia patients. Am J Med Genet B Neuropsychiatr Genet 2008 Apr 30.

30. Ates MA, Algul A, Gecici O, Semiz UB, Noyan O, Basoglu C, Ebrinc S, Uzun O, Cetin M. Substance use in early adult male with first episode psychosis. Neurol Psychiatr Brain Res 2008: 15: 93-98

31. Algul A, Ates MA, Gulsun M, Semiz UB, Gecici O, Noyan O,Cetin M. epileptic seizure precipitated by using venlafaxine-extended release form: a case report. Noropsikiyatri Arsivi - Archives of Neuropsychiatry 2008; 45(2):62-64 ( in Turkish).

32. Cetin M, Antidepressants, antipsychotics: Reliability of metaanalyses.Klinik Psikofarmakoloji Bulteni –Bulletin of Clinical Psychopharmacology, 2008: 18(4):245-250 ( in Turkish).

33. Semiz UB, Algul, A, Cetin M.Alexithimia and aggression in patients with antisocial personality disorder. European Psychiatry 2008; 23: (Suppl.2) S91

34. Algul A, Semiz UB,Ates MA, Cetin M.Asssociation between psychosocial distress, subjective sleep qualityof life in patients with obesity: A preliminary study.European Psychiatry 2008; 23: (Suppl.2) S62-S63.

35. Ebrinc S, Sahan A, Semiz UB, Cetin M. Effect of sertraline treatment on regional cerebral blood flow in OCD. European Neuropsychopharmacology 2008;18: ( Suppl. 4) S62-S63.

36. Ebrinc S, Semiz UB, Oznur T, Cetin M. Neuropsychological assessment of unmadecated patients with OCD.European Neuropsychopharmacology 2008;18: ( Suppl. 4) S62-S63.

37. Algul A, Ates MA, Gulsun M, Doruk A, Semiz UB, Basoglu C, Ebrinc S, Cetin M, The relationship between self-mutilation, aggression, childhood trauma history and dissociative experiences in antisocial personality disorder.Anadolu Psikiyatri Dergisi- Anatolinan Journal of Psychiarty 2009;10:278-285( in Turkish).

38. Korkmaz A, Ates MA, Algul A, Basoglu C, Physiological approach to neuropsychiatric diseases; role of autonomic nervous system and melatonin. Klinik Psikofarmakoloji Bulteni, Bulletin of Clinical Psychopharmacology 2009;19:173-182 ( in Turkish).

39. Ates MA, Algul A, Gulsun M,Geçici O, Ozdemir B, Basoglu C, Semiz UB, Servet h antisocial personality disorder Noropsikiyatri Arsivi - Archives of Neuropsychiatry 2009;46:135-139 ( in Turkish).

40. Ates MA, Algul A, Semiz UB, Gecici O, Basoglu C, Ebrinc S, Cetin M. Clinical characteristics of self-mutilating behavior in Turkish male subjects with antisocial personality disorder. International Journal of Social Psychiatry 2009

41. Algul A, Sen H, M. Ates, Yen T, Durmaz O, Ozkan S, Basoglu C, Semiz UB, Ebrinc S, Daglı G, Cetin M,. "ElektrokonvUlzif tedavide propofol ile propofol remifentanil kombinasyonun nobet suresi ve hemodinami Uzerine etkisi", Klinik Psikofarmakoloji Bulteni, Bulletin of Clinical Psychopharmacology 2009;19, 24-28 ( in Turkish).

42. Basoglu C, M. Ates A, Algul A, İpçioglu M, Geçici O, Yılmaz O, Semiz UB, S Ebrinc S Gulsun M, Ozcan O, Kilic S, Cetin M.Adjuvant folate with escitalopram treatment and homocystein, folate, vitamin B-12 levels in patients with major depressive disorder Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2009; 19(2):135-142.

43. Algul A, Ates MA, Semiz UB, Basoglu C, Ebrinc S, Gecici O, Gülsün M, Kardesoglu E, Cetin M. Evaluation of general psychopathology, subjective sleep quality, and health-related quality of life in patients with obesity. Int J Psychiatry Med. 2009;39(3):297-312.

44. Algul, A, Gulsun M, Geçici O,Ozdemir B, Basoglu C, Semiz UB, Ebrinc S,Cetin M, The relationship between alexithymia, aggression and psychopathy in young adult males with antisocial personality disorder.Noropsikiyatri Arsivi - Archives of Neuropsychiatry 2009; 46: 135-9 ( in Turkish).

45. Cetin M, Aricioglu F, Pharmacovigilance and its significance in psychopharmacology,Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology, 2009; 19(4):335-339 ( in Turkish).

46. Cetin M,Aricioglu F, On the debate of original drug versus generic drug. Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology, 2009; 19(3):211-213 ( in Turkish).

47. Cetin M, Acikel C. In perspective of meta-analyses: Are all of the antidepressants similar? Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology, 2009; 19(2):87-92 ( in Turkish).

48. Cetin M, Kilic S . How to comprehend the recent meta-analyses conducted on typical and atypical antipsychotics?Klinik Psikofarmakoloji Bulteni –Bulletin of Clinical Psychopharmacology, 2009; 19(1):1-4 ( in Turkish).

49. Başoğlu C, Cetin M, Oner O, Ebrinç S, Semiz UB, Kandilcioğlu H, Silit E, Kizilkaya E.Comparison of right thalamus and temporal cortex metabolite levels of drug-naive first-episode psychotic and chronic schizophrenia in patients Turk Psikiyatri Derg.2006 Summer;17(2):85-91.

50. Barlas IO, Cetin M, Erdal ME, Semiz UB, Basoglu C, Ay ME, Herken H, Uzun O. Lack of association between DRD3 gene polymorphism and response to clozapine in Turkish schizoprenia patients. Am J Med Genet B Neuropsychiatr Genet. 2009 Jan 5;150B(1):56-60.

51. Cetin M,, Aricioglu F. Pharmacoeconomics and its importance in psychiatry. Klinik Psikofarmakoloji Bulteni –Bulletin of Clinical Psychopharmacology, 2010; 20(1):1-4 ( in Turkish).

52. MacKay M, Cetin M, Baker G, Dursun S. Modulation of central nitric oxide as a therapeutic strategy for schizophrenia. Klinik Psikofarmakoloji Bulteni –Bulletin of Clinical Psychopharmacology, 2010; 20(2):115-119

53. Basoglu C, Oner O, Ates AM, Algul A, Semiz UB, Ebrinc S, Cetin M, Ozcan O, Ipcioglu OM. Association between symptom improvement and change of body mass index, lipid profile, and leptin, ghrelin, and cholecystokinin levels during 6-week olanzapine treatment in patients with first-episode psychosis. J Clin Psychopharmacol. 2010 Oct;30(5):636-8

54. Cetin M. Escitalopram treatment of fibromyalgia: a pilot study.European Psychiatry 2010;25, (Suppl 1) S 72

55. Cetin M,A comparative study of atypical antiosychotics on sexual dysfunction.International Journal of Neuropsychopharmacology, 2010; Vol 13 (Suppl. 1) S 89

56. Dursun S, Hallak J, Devarajan S, Baker G, Cetin M High-dose antipsychotic medication; a practical pocket checklist. Klinik Psikofarmakoloji Bulteni, Bulletin of Clinical Psychopharmacology 2010;20:187-188.

57. Aricioglu, F, Cetin M.Personalized drug therapy in psychiatry: Maybe a little old or a little new, but the treatment of future. Klinik Psikofarmakoloji Bulteni, Bulletin of Clinical Psychopharmacology 2010;20: 269-271 ( in Turkish).

58. Basoglu C, Oner O, Gunes C, Semiz UB, Ates AM, Algul A, Ebrinc S, Cetin M, Ozcan O, Ipcioglu O. Plasma orexin A, ghrelin, cholecystokinin, visfatin, leptin and agouti-related protein levels during 6-week olanzapine treatment in first-episode male patients with psychosis. Int Clin Psychopharmacol. 2010 May;25(3):165-71.

59. Alpay Ates M, Algul A, Semiz UB, Gecici O, Basoglu C, Ebrinc S, Cetin M. Clinical characteristics of self-mutilating behavior in Turkish male subjects with antisocial personality disorder: relationship to psychopathy. Int J Soc Psychiatry. 2011 May;57(3):237-47. Epub 2009 Nov 11

60. Basoglu C, Oner O, Ates A, Algul A, Bez Y, Ebrinc S, Cetin M. Temperament traits and psychopathy in a group of patients with antisocial personality disorder. Compr Psychiatry. 2011 Mar 10. [Epub ahead of print] ,

61. Balibey H, Basoglu C, Lundgren S, Babaoglu MO, Yasar U, Herken H, Rane A, Bozkurt A, Cetin M. CYP1A2*1F polymorphism decreases clinical response to clozapine in patients with schizophrenia. Klinik Psikofarmakoloji Bülteni- Bulletin of Clinical Psychopharmacology 2011;21(2):93-9

62. Basoglu C, Oner O, Ates A, Algul A, Bez Y, Cetin M, Herken H, Erdal ME, Munir KM. Synaptosomal-associated protein 25 gene polymorphisms and antisocial personality disorder: association with temperament and psychopathy.Can J Psychiatry. 2011 Jun;56(6):341-7.

63. Cetin M. Psychotropic Drug Use in Pregnancy: An Update. Psikofarmakoloji Bulteni - Bulletin of Clinical Psychopharmacology 2011;21(2):161-73.